Pulsenmore (PLSM) Common Equity (2025)
Pulsenmore (PLSM) posted Common Equity of $26.0 million for Q4 2025.
Pulsenmore (PLSM) Common Equity (2025) Analysis & Trends
Pulsenmore has reported Common Equity for 1 years, with the latest figure at $26.0 million in Q4 2025.
- Quarterly Common Equity changed N/A year-over-year to $26.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.0 million (changed N/A YoY) and the FY2025 annual result came in at $26.0 million, changed N/A from the prior year.
- Common Equity held at $26.0 million in Q4 2025 per PLSM's latest filing.
- Over five years, Common Equity peaked at $26.0 million in Q4 2025 and troughed at $26.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.60 Bn | 197.00 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.14 Bn | 109.92 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 74.21 Bn | 73.67 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.58 Bn | 47.32 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.93 Bn | 32.98 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.16 Bn | 22.67 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Pulsenmore | 18.79 Mn | -2.88 Mn | - | 26.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.05 Mn |